Atypical (second-generation) antipsychotic

Caplyta (lumateperone) Withdrawal

Caplyta (lumateperone) is a newer atypical antipsychotic used for schizophrenia and bipolar depression. Published data on its discontinuation syndrome specifically are limited, so guidance is extrapolated from the antipsychotic class as a whole: abrupt cessation can produce rebound symptoms, insomnia, and (less commonly) withdrawal dyskinesia. Taper rather than stop suddenly.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~18 hours for the parent compound. Lumateperone is a newer agent (FDA-approved 2019), so published discontinuation data are limited.

Withdrawal timeline

Onset1-4 days after stopping

Insomnia and nausea are the most commonly reported early signs across the antipsychotic class.

PeakWeek 1-2

Rebound of the underlying condition (mood or psychotic symptoms) and sleep disruption tend to be most prominent here.

Resolution2-4 weeks

Most discontinuation symptoms settle within a few weeks; relapse of the underlying illness is a separate, longer-horizon risk.

Common symptoms

  • Insomnia
  • Nausea
  • Anxiety or agitation
  • Return of underlying symptoms

Less common

  • Sweating
  • Dizziness
  • Irritability
  • Vivid dreams

Notable / pattern-defining symptoms

Withdrawal-emergent dyskinesia - abnormal involuntary movements that can appear when an antipsychotic is reduced or stopped. Usually transient but should be reported to the prescriber.

Tapering guidance

  • Reduce gradually rather than stopping abruptly, even though Caplyta is dosed once daily at a single strength - your prescriber may use alternate-day dosing or a cross-taper.
  • Watch for new involuntary movements during the taper and report them.
  • Coordinate closely with the prescribing physician; antipsychotic discontinuation carries a real relapse risk.

Where ketamine therapy fits

Ketamine therapy does not treat antipsychotic withdrawal and is not a substitute for an antipsychotic. Decisions about ketamine in someone taking or tapering an antipsychotic should be made jointly with the prescribing psychiatrist, particularly when there is any history of psychosis or mania.

Frequently asked questions

How long does Caplyta withdrawal last?

Discontinuation symptoms from antipsychotics generally peak within the first 1-2 weeks and resolve within a few weeks. Caplyta is newer, so individual experiences vary and data are limited.

Can I stop Caplyta abruptly?

It is safer to taper under your prescriber. Abrupt antipsychotic cessation can cause insomnia, nausea, rebound of the underlying condition, and occasionally withdrawal-emergent movement symptoms.

Can ketamine therapy replace Caplyta?

No. Ketamine is not an antipsychotic and does not replace one. Any change to an antipsychotic should be coordinated with the prescribing psychiatrist.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.